A citation-based method for searching scientific literature

Approved drugs ezetimibe and disulfiram enhance mitochondrial Ca2+ uptake and suppress cardiac arrhythmogenesis.
Paulina Sander, Michael Feng, Maria K Schweitzer, Fabiola Wilting, Sophie M Gutenthaler, Daniela M Arduino, Sandra Fischbach, Lisa Dreizehnter, Alessandra Moretti, Thomas Gudermann, Fabiana Perocchi, Johann Schredelseker. Br J Pharmacol 2021
Times Cited: 4



Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review.
Thomas M Roston, Karolina Jones, Nathaniel M Hawkins, J Martijn Bos, Peter J Schwartz, Frances Perry, Michael J Ackerman, Zachary W M Laksman, Padma Kaul, Krystien V V Lieve, Joseph Atallah, Andrew D Krahn, Shubhayan Sanatani. Heart Rhythm 2018
Times Cited: 42




List of shared articles



Times cited

Avoiding fatal implantable cardioverter-defibrillator complications in patients with catecholaminergic polymorphic ventricular tachycardia by not implanting them.
Christian van der Werf, Arthur A M Wilde. J Electrocardiol 2022
0


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy